1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Acute Liver Failure Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Hepatocyte Transplantation 1.2.3 Assisted Liver Transplantation 1.2.4 Xenotransplantation 1.3 Market by Application 1.3.1 Global Acute Liver Failure Treatment Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Liver Academic and Research Institutes 1.3.5 Forensic Laboratories 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Acute Liver Failure Treatment Market Perspective (2017-2028) 2.2 Acute Liver Failure Treatment Growth Trends by Region 2.2.1 Acute Liver Failure Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Acute Liver Failure Treatment Historic Market Size by Region (2017-2022) 2.2.3 Acute Liver Failure Treatment Forecasted Market Size by Region (2023-2028) 2.3 Acute Liver Failure Treatment Market Dynamics 2.3.1 Acute Liver Failure Treatment Industry Trends 2.3.2 Acute Liver Failure Treatment Market Drivers 2.3.3 Acute Liver Failure Treatment Market Challenges 2.3.4 Acute Liver Failure Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Acute Liver Failure Treatment Players by Revenue 3.1.1 Global Top Acute Liver Failure Treatment Players by Revenue (2017-2022) 3.1.2 Global Acute Liver Failure Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Acute Liver Failure Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Acute Liver Failure Treatment Revenue 3.4 Global Acute Liver Failure Treatment Market Concentration Ratio 3.4.1 Global Acute Liver Failure Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Acute Liver Failure Treatment Revenue in 2021 3.5 Acute Liver Failure Treatment Key Players Head office and Area Served 3.6 Key Players Acute Liver Failure Treatment Product Solution and Service 3.7 Date of Enter into Acute Liver Failure Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Acute Liver Failure Treatment Breakdown Data by Type 4.1 Global Acute Liver Failure Treatment Historic Market Size by Type (2017-2022) 4.2 Global Acute Liver Failure Treatment Forecasted Market Size by Type (2023-2028) 5 Acute Liver Failure Treatment Breakdown Data by Application 5.1 Global Acute Liver Failure Treatment Historic Market Size by Application (2017-2022) 5.2 Global Acute Liver Failure Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Acute Liver Failure Treatment Market Size (2017-2028) 6.2 North America Acute Liver Failure Treatment Market Size by Country (2017-2022) 6.3 North America Acute Liver Failure Treatment Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Acute Liver Failure Treatment Market Size (2017-2028) 7.2 Europe Acute Liver Failure Treatment Market Size by Country (2017-2022) 7.3 Europe Acute Liver Failure Treatment Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Acute Liver Failure Treatment Market Size (2017-2028) 8.2 Asia-Pacific Acute Liver Failure Treatment Market Size by Country (2017-2022) 8.3 Asia-Pacific Acute Liver Failure Treatment Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Acute Liver Failure Treatment Market Size (2017-2028) 9.2 Latin America Acute Liver Failure Treatment Market Size by Country (2017-2022) 9.3 Latin America Acute Liver Failure Treatment Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Acute Liver Failure Treatment Market Size (2017-2028) 10.2 Middle East & Africa Acute Liver Failure Treatment Market Size by Country (2017-2022) 10.3 Middle East & Africa Acute Liver Failure Treatment Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Novartis AG 11.1.1 Novartis AG Company Detail 11.1.2 Novartis AG Business Overview 11.1.3 Novartis AG Acute Liver Failure Treatment Introduction 11.1.4 Novartis AG Revenue in Acute Liver Failure Treatment Business (2017-2022) 11.1.5 Novartis AG Recent Development 11.2 Bayer AG 11.2.1 Bayer AG Company Detail 11.2.2 Bayer AG Business Overview 11.2.3 Bayer AG Acute Liver Failure Treatment Introduction 11.2.4 Bayer AG Revenue in Acute Liver Failure Treatment Business (2017-2022) 11.2.5 Bayer AG Recent Development 11.3 Cardiorentis AG 11.3.1 Cardiorentis AG Company Detail 11.3.2 Cardiorentis AG Business Overview 11.3.3 Cardiorentis AG Acute Liver Failure Treatment Introduction 11.3.4 Cardiorentis AG Revenue in Acute Liver Failure Treatment Business (2017-2022) 11.3.5 Cardiorentis AG Recent Development 11.4 Cytokinetics, Inc. 11.4.1 Cytokinetics, Inc. Company Detail 11.4.2 Cytokinetics, Inc. Business Overview 11.4.3 Cytokinetics, Inc. Acute Liver Failure Treatment Introduction 11.4.4 Cytokinetics, Inc. Revenue in Acute Liver Failure Treatment Business (2017-2022) 11.4.5 Cytokinetics, Inc. Recent Development 11.5 Orion Corporation 11.5.1 Orion Corporation Company Detail 11.5.2 Orion Corporation Business Overview 11.5.3 Orion Corporation Acute Liver Failure Treatment Introduction 11.5.4 Orion Corporation Revenue in Acute Liver Failure Treatment Business (2017-2022) 11.5.5 Orion Corporation Recent Development 11.6 Bristol-Myers Squibb Company 11.6.1 Bristol-Myers Squibb Company Company Detail 11.6.2 Bristol-Myers Squibb Company Business Overview 11.6.3 Bristol-Myers Squibb Company Acute Liver Failure Treatment Introduction 11.6.4 Bristol-Myers Squibb Company Revenue in Acute Liver Failure Treatment Business (2017-2022) 11.6.5 Bristol-Myers Squibb Company Recent Development 11.7 PhaseBio Pharmaceuticals, InC 11.7.1 PhaseBio Pharmaceuticals, InC Company Detail 11.7.2 PhaseBio Pharmaceuticals, InC Business Overview 11.7.3 PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Introduction 11.7.4 PhaseBio Pharmaceuticals, InC Revenue in Acute Liver Failure Treatment Business (2017-2022) 11.7.5 PhaseBio Pharmaceuticals, InC Recent Development 11.8 Merck & Co 11.8.1 Merck & Co Company Detail 11.8.2 Merck & Co Business Overview 11.8.3 Merck & Co Acute Liver Failure Treatment Introduction 11.8.4 Merck & Co Revenue in Acute Liver Failure Treatment Business (2017-2022) 11.8.5 Merck & Co Recent Development 11.9 CVie Therapeutics Limited 11.9.1 CVie Therapeutics Limited Company Detail 11.9.2 CVie Therapeutics Limited Business Overview 11.9.3 CVie Therapeutics Limited Acute Liver Failure Treatment Introduction 11.9.4 CVie Therapeutics Limited Revenue in Acute Liver Failure Treatment Business (2017-2022) 11.9.5 CVie Therapeutics Limited Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Acute Liver Failure Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Hepatocyte Transplantation Table 3. Key Players of Assisted Liver Transplantation Table 4. Key Players of Xenotransplantation Table 5. Global Acute Liver Failure Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Acute Liver Failure Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Acute Liver Failure Treatment Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Acute Liver Failure Treatment Market Share by Region (2017-2022) Table 9. Global Acute Liver Failure Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Acute Liver Failure Treatment Market Share by Region (2023-2028) Table 11. Acute Liver Failure Treatment Market Trends Table 12. Acute Liver Failure Treatment Market Drivers Table 13. Acute Liver Failure Treatment Market Challenges Table 14. Acute Liver Failure Treatment Market Restraints Table 15. Global Acute Liver Failure Treatment Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Acute Liver Failure Treatment Market Share by Players (2017-2022) Table 17. Global Top Acute Liver Failure Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Liver Failure Treatment as of 2021) Table 18. Ranking of Global Top Acute Liver Failure Treatment Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Acute Liver Failure Treatment Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Acute Liver Failure Treatment Product Solution and Service Table 22. Date of Enter into Acute Liver Failure Treatment Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Acute Liver Failure Treatment Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Acute Liver Failure Treatment Revenue Market Share by Type (2017-2022) Table 26. Global Acute Liver Failure Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Acute Liver Failure Treatment Revenue Market Share by Type (2023-2028) Table 28. Global Acute Liver Failure Treatment Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Acute Liver Failure Treatment Revenue Market Share by Application (2017-2022) Table 30. Global Acute Liver Failure Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Acute Liver Failure Treatment Revenue Market Share by Application (2023-2028) Table 32. North America Acute Liver Failure Treatment Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Acute Liver Failure Treatment Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Acute Liver Failure Treatment Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Acute Liver Failure Treatment Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Acute Liver Failure Treatment Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Acute Liver Failure Treatment Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Acute Liver Failure Treatment Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Acute Liver Failure Treatment Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Acute Liver Failure Treatment Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Acute Liver Failure Treatment Market Size by Country (2023-2028) & (US$ Million) Table 42. Novartis AG Company Detail Table 43. Novartis AG Business Overview Table 44. Novartis AG Acute Liver Failure Treatment Product Table 45. Novartis AG Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million) Table 46. Novartis AG Recent Development Table 47. Bayer AG Company Detail Table 48. Bayer AG Business Overview Table 49. Bayer AG Acute Liver Failure Treatment Product Table 50. Bayer AG Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million) Table 51. Bayer AG Recent Development Table 52. Cardiorentis AG Company Detail Table 53. Cardiorentis AG Business Overview Table 54. Cardiorentis AG Acute Liver Failure Treatment Product Table 55. Cardiorentis AG Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million) Table 56. Cardiorentis AG Recent Development Table 57. Cytokinetics, Inc. Company Detail Table 58. Cytokinetics, Inc. Business Overview Table 59. Cytokinetics, Inc. Acute Liver Failure Treatment Product Table 60. Cytokinetics, Inc. Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million) Table 61. Cytokinetics, Inc. Recent Development Table 62. Orion Corporation Company Detail Table 63. Orion Corporation Business Overview Table 64. Orion Corporation Acute Liver Failure Treatment Product Table 65. Orion Corporation Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million) Table 66. Orion Corporation Recent Development Table 67. Bristol-Myers Squibb Company Company Detail Table 68. Bristol-Myers Squibb Company Business Overview Table 69. Bristol-Myers Squibb Company Acute Liver Failure Treatment Product Table 70. Bristol-Myers Squibb Company Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million) Table 71. Bristol-Myers Squibb Company Recent Development Table 72. PhaseBio Pharmaceuticals, InC Company Detail Table 73. PhaseBio Pharmaceuticals, InC Business Overview Table 74. PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Product Table 75. PhaseBio Pharmaceuticals, InC Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million) Table 76. PhaseBio Pharmaceuticals, InC Recent Development Table 77. Merck & Co Company Detail Table 78. Merck & Co Business Overview Table 79. Merck & Co Acute Liver Failure Treatment Product Table 80. Merck & Co Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million) Table 81. Merck & Co Recent Development Table 82. CVie Therapeutics Limited Company Detail Table 83. CVie Therapeutics Limited Business Overview Table 84. CVie Therapeutics Limited Acute Liver Failure Treatment Product Table 85. CVie Therapeutics Limited Revenue in Acute Liver Failure Treatment Business (2017-2022) & (US$ Million) Table 86. CVie Therapeutics Limited Recent Development Table 87. Research Programs/Design for This Report Table 88. Key Data Information from Secondary Sources Table 89. Key Data Information from Primary Sources List of Figures Figure 1. Global Acute Liver Failure Treatment Market Share by Type: 2021 VS 2028 Figure 2. Hepatocyte Transplantation Features Figure 3. Assisted Liver Transplantation Features Figure 4. Xenotransplantation Features Figure 5. Global Acute Liver Failure Treatment Market Share by Application in 2021 & 2028 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Liver Academic and Research Institutes Case Studies Figure 9. Forensic Laboratories Case Studies Figure 10. Acute Liver Failure Treatment Report Years Considered Figure 11. Global Acute Liver Failure Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Acute Liver Failure Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Acute Liver Failure Treatment Market Share by Region: 2021 VS 2028 Figure 14. Global Acute Liver Failure Treatment Market Share by Players in 2021 Figure 15. Global Top Acute Liver Failure Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Liver Failure Treatment as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Acute Liver Failure Treatment Revenue in 2021 Figure 17. North America Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. North America Acute Liver Failure Treatment Market Share by Country (2017-2028) Figure 19. United States Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Acute Liver Failure Treatment Market Share by Country (2017-2028) Figure 23. Germany Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. France Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. U.K. Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Italy Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Russia Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Nordic Countries Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Acute Liver Failure Treatment Market Share by Region (2017-2028) Figure 31. China Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Japan Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. South Korea Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Southeast Asia Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. India Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Australia Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Acute Liver Failure Treatment Market Share by Country (2017-2028) Figure 39. Mexico Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Brazil Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Acute Liver Failure Treatment Market Share by Country (2017-2028) Figure 43. Turkey Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Saudi Arabia Acute Liver Failure Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Novartis AG Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022) Figure 46. Bayer AG Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022) Figure 47. Cardiorentis AG Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022) Figure 48. Cytokinetics, Inc. Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022) Figure 49. Orion Corporation Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022) Figure 50. Bristol-Myers Squibb Company Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022) Figure 51. PhaseBio Pharmaceuticals, InC Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022) Figure 52. Merck & Co Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022) Figure 53. CVie Therapeutics Limited Revenue Growth Rate in Acute Liver Failure Treatment Business (2017-2022) Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Novartis AG Bayer AG Cardiorentis AG Cytokinetics, Inc. Orion Corporation Bristol-Myers Squibb Company PhaseBio Pharmaceuticals, InC Merck & Co CVie Therapeutics Limited